Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PSMA PET Imaging of Recurrent Prostate Cancer

Trial Profile

PSMA PET Imaging of Recurrent Prostate Cancer

Phase of Trial: Phase II

Latest Information Update: 07 Jan 2019

At a glance

  • Drugs Gallium 68 PSMA (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 29 Aug 2018 New trial record
    • 12 Aug 2018 According to Telix Pharmaceuticals media release, first two patients in a 500 patient hes been imaged at Memorial Sloan Kettering Cancer Center.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top